IL1A and head and neck squamous cell carcinoma: To determine if radiotherapy (RT) releases IL-1 ligands, we first used 3 human HNSCC cell lines (FaDu, Cal-27 and SQ20B) with varying sensitivity to RT (Fig. 1A) and performed clonogenic survival assays 24 h after RT exposure.